MERONEM

This brand name is authorized in Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug MERONEM contains one active pharmaceutical ingredient (API):

1 Meropenem trihydrate UNII YOP6PX0BAO - MEROPENEM ANHYDROUS

Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). Read about Meropenem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MERONEM IV 1g Powder for solution for injection or infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH02	Meropenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502302501159317, 502302502155315, 502302503151313, 502302504158311, 522718040080117, 522718040080217, 522718040080317, 522718040080417
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5012-MEE-0320
Country: EE	Ravimiamet	Identifier(s): 1026537, 1026559, 1528286, 1528297
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60639, 60640
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 466002, 555834
Country: FR	Base de données publique des médicaments	Identifier(s): 67353986
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 43818, 43821
Country: HK	Department of Health Drug Office	Identifier(s): 40372
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6435, 6436
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100042811, 100042828
Country: SG	Health Sciences Authority	Identifier(s): 09033P, 14471P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/20.1.1/0340, 29/20.1.1/0341